Results
SALVUS
The ERIS team proudly announces that the SALVUS consortium has received an EU grant. Prof. Rosamunde Van Brakel, from the Law, Science, Technology and Society Research Group of VUB, will coordinate this project for VUB.
Read more
GULLIVER BIOMED
Read more
Get to know Maarten De Ruyck
Meet Maarten, Program Manager of StartLab.Brussels for Academics. In his role, he is on a mission to connect VUB researchers with the guidance of the StartLab.Brussels entrepreneurship program, helping them transform their ideas into real-world innovations.
Read more
Serendipity in the lab: the camelid blood experiment that changed everything
In 1989, during a routine lab experiment with students at Vrije Universiteit Brussel (VUB), professor Raymond Hamers and his wife professor Cécile Casterman made a spontaneous choice: to use camelid blood — leftover from a previous experiment — because no other samples were available.
Read more
VUB's Revolutionary Radar Technology Seeks Partners
VUB researchers worked on a revolutionary tool for the construction and inspection industry. This technology offers a non-invasive way to get a clear picture of what's hidden inside walls.
Read more
Belgium Celebrates 100,000 Public Charging Points
Belgium reached the milestone of 100,000 public charging points. The achievement was celebrated at a symbolic event co-hosted by the VUB MOBI Electromobility Research Centre and EV Belgium.
Read more
How Cocoa Variety and Yeasts Determine Chocolate Flavour
VUB research reveals how the type of cocoa bean and the yeasts involved in fermentation have a significant impact on the ultimate flavour of chocolate.
Read more
Luceda Photonics joins forces with Semitronix to accelerate photonics innovation
Luceda Photonics announced its acquisition by SMTX Technologies Singapore Pte. Ltd., part of Semitronix Group. This strategic partnership combines Luceda’s expertise in photonic integrated circuit (PIC) design software with Semitronix’s advanced semiconductor solutions.
Read more
ORION
The ERIS team proudly announces that the ORION consortium has received an EU grant. Prof. Vagelis Papakonstantinou, from the Law, Science, Technology and Society Research Group of VUB, will coordinate this project for VUB.
Read more
Spica Therapeutics Secures €1M Grant to Advance Cancer Therapy with VUB & VIB Partnership
Biotech company Spica Therapeutics secured a €1M VLAIO grant to advance macrophage-targeted cancer therapy. As part of the VLAIO-supported initiative, Spica will collaborate with VUB and VIB.
Read more